Literature DB >> 18206153

Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study.

Manon C W Spaander1, Sarwa Darwish Murad, Henk R van Buuren, Bettina E Hansen, Ernst J Kuipers, Harry L A Janssen.   

Abstract

BACKGROUND: Esophagogastric variceal bleeding is the most important complication of extrahepatic portal vein thrombosis (EPVT) and is usually treated endoscopically. Little is known about the prognosis of these patients.
OBJECTIVES: To investigate the long-term clinical outcome and efficacy of endoscopic treatment in patients with esophagogastric variceal bleeding secondary to EPVT.
DESIGN: Retrospective observational study. SETTINGS: Single university center. PATIENTS: Twenty-seven consecutive patients with esophagogastric variceal bleeding, secondary to noncirrhotic, nonmalignant EPVT, who underwent endoscopic treatment between 1982 and 2005.
INTERVENTIONS: Endoscopic band ligation and/or endoscopic sclerotherapy. MAIN OUTCOME MEASUREMENTS: The overall rebleeding risk, overall survival, complications of the endoscopic procedures, and predictive values of rebleeding. Analyses were performed by the Kaplan-Meier method and univariate Cox regression.
RESULTS: All patients were followed-up after the first endoscopically treated variceal bleeding. A total of 241 endoscopic procedures were performed. In all patients, initial control of bleeding was obtained. The overall rebleeding risk was 23% (95% CI, 0%-24%) at 1 year and 37% (95% CI, 43%-83%) at 5 years. Extension of thrombosis into the splenic vein and the presence of fundal varices were significant predictors of rebleeding, with a nearly 5-fold increased risk for patients with EPVT and fundal varices at the time of the first variceal hemorrhage (hazard ratio 5.07, P = .01). A portosystemic shunt procedure was performed in 5 patients: 4 for variceal bleeding and in one patient for refractory ascites. Seven patients died, none from variceal bleeding. Overall 5-year and 10-year survivals were 100% and 62% (95% CI, 38%-96%), respectively. LIMITATIONS: Retrospective design.
CONCLUSIONS: In patients with variceal bleeding secondary to EPVT endoscopic treatment, in particular, band ligation appears safe and effective. EPVT-related mortality is primarily determined by other causes than variceal bleeding.

Entities:  

Mesh:

Year:  2008        PMID: 18206153     DOI: 10.1016/j.gie.2007.08.023

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  11 in total

1.  [19-year-old kick-boxer with hematemesis and splenomegaly].

Authors:  H Wobser; J Schölmerich; R Büttner
Journal:  Internist (Berl)       Date:  2010-02       Impact factor: 0.743

Review 2.  Portal vein thrombosis.

Authors:  Yogesh K Chawla; Vijay Bodh
Journal:  J Clin Exp Hepatol       Date:  2015-01-06

3.  Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in Adults.

Authors:  Indrani Sen; Lavanya Yohanathan; Jussi M Kärkkäinen; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2020-05-18       Impact factor: 3.452

4.  Splenic artery embolization in a woman with bleeding gastric varices and splenic vein thrombosis: a case report.

Authors:  Bernd Saugel; Jochen Gaa; Veit Phillip; Roland M Schmid; Wolfgang Huber
Journal:  J Med Case Rep       Date:  2010-08-04

5.  Management of portal hypertensive upper gastrointestinal bleeding: Report of the Coorg Consensus workshop of the Indian Society of Gastroenterology Task Force on Upper Gastrointestinal Bleeding.

Authors:  Shivaram P Singh; Manav Wadhawan; Subrat K Acharya; Sawan Bopanna; Kaushal Madan; Manoj K Sahoo; Naresh Bhat; Sri P Misra; Ajay Duseja; Amar Mukund; Anil C Anand; Ashish Goel; Bonthala S Satyaprakash; Joy Varghese; Manas K Panigrahi; Manu Tandan; Mihir K Mohapatra; Pankaj Puri; Pravin M Rathi; Rajkumar P Wadhwa; Sunil Taneja; Varghese Thomas; Vikram Bhatia
Journal:  Indian J Gastroenterol       Date:  2021-12-10

6.  Sevoflurane may be more beneficial than propofol in patients receiving endoscopic variceal ligation and endoscopic variceal sclerotherapy: A randomized, double-blind study.

Authors:  Linghua Tang; Huimin Liu; Yang Wu; Mei Li; Wei Li; Meng Jiang; Jiabao Hou; Ying Jiang; Zhongyuan Xia; Qingtao Meng
Journal:  Exp Ther Med       Date:  2017-08-09       Impact factor: 2.447

7.  Variceal band ligation in the prevention of variceal bleeding: a multicenter trial.

Authors:  Asma Ouakaa-Kchaou; Jamel Kharrat; Khaoula Mir; Boussourra Houda; Nabil Abdelli; Salem Ajmi; Msaddek Azzouz; Hatem Ben Abdallah; Nabyl Ben Mami; Slim Bouzaidi; Sofiene Chouaib; Lamia Golli; Wissem Melki; Taoufik Najjar; Hammouda Saffar; Najet Belhadj; Abdeljabbar Ghorbel
Journal:  Saudi J Gastroenterol       Date:  2011 Mar-Apr       Impact factor: 2.485

8.  Gastrointestinal Bleeding due to Pancreatic Disease-Related Portal Hypertension.

Authors:  Kexin Zheng; Xiaozhong Guo; Ji Feng; Zhaohui Bai; Xiaodong Shao; Fangfang Yi; Yongguo Zhang; Rui Zhang; Han Liu; Fernando Gomes Romeiro; Xingshun Qi
Journal:  Gastroenterol Res Pract       Date:  2020-03-27       Impact factor: 2.260

9.  Esophageal variceal ligation in the secondary prevention of variceal bleeding: Result of long term follow-up.

Authors:  Mounia Lahbabi; Ihssane Mellouki; Nouredine Aqodad; Mohammed Elabkari; Mounia Elyousfi; Sidi Adil Ibrahimi; Dafr Allah Benajah
Journal:  Pan Afr Med J       Date:  2013-05-03

10.  Outcome of the Pediatric Patients with Portal Cavernoma: The Retrospective Study for 10 Years Focusing on Recurrent Variceal Bleeding.

Authors:  Hongjie Guo; Fabao Hao; Chunbao Guo; Yang Yu
Journal:  Gastroenterol Res Pract       Date:  2016-02-02       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.